Loading...
XHKG
0399
Market cap37mUSD
Dec 05, Last price  
0.14HKD
1D
0.00%
1Q
-72.12%
Jan 2017
-77.38%
IPO
-91.19%
Name

Innovative Pharmaceutical Biotech Ltd

Chart & Performance

D1W1MN
XHKG:0399 chart
P/E
—
P/S
141.42
EPS
—
Div Yield, %
—
Shrs. gr., 5y
3.38%
Rev. gr., 5y
-32.19%
Revenues
2m
-68.28%
32,028,00083,111,000317,041,000374,442,000483,947,00090,193,00025,475,00010,050,00036,184,50033,976,00019,908,0009,187,00015,811,00018,589,00014,580,00015,189,00011,145,0008,075,0006,593,0002,091,000
Net income
-346m
L
-52,953,000-64,052,000-68,621,000745,205,00011,262,0005,247,000-123,882,000-72,839,000-569,300,500-451,684,000-236,865,000-169,788,000-231,048,000-260,272,000-407,562,000-395,752,000296,538,000-245,698,000103,403,000-345,937,000
CFO
-11m
L+27.49%
3,389,0003,492,0003,458,000-46,716,000-39,507,00067,645,000-25,250,000-37,436,000-67,204,000-35,571,000-133,085,000120,035,000-14,920,000-29,492,000-36,224,000-25,006,000-12,335,000-17,640,000-8,279,000-10,555,000
Dividend
Dec 10, 20030.02 HKD/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Innovative Pharmaceutical Biotech Limited, an investment holding company, engages in the trading of beauty equipment and products in the People's Republic of China and Hong Kong. The company operates in two segments, Trading of Beauty Products, and Research and Development. It is also involved in the securities investment; research, development, and commercialization of oral insulin products; distribution of bio-industrial products; and provision of genetic testing services. The company was formerly known as United Gene High-Tech Group Limited and changed its name to Innovative Pharmaceutical Biotech Limited in September 2015. Innovative Pharmaceutical Biotech Limited is headquartered in Sheung Wan, Hong Kong.
URL
http://www.ipb.asia/
IPO date
Jul 18, 2008
Employees
22
Domiciled in
HK
Incorporated in
BM

Valuation

Title
HKD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT